EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD

Joon Young Choi iD, Chin Kook Rhee iD, Kwang Ha Yoo, Ki-Suck Jung, Jae Ha Lee, Hyoung Kyu Yoon, Seung Won Ra, Myung Goo Lee, Yong Suk Jo iD

Therapeutic Advances in Respiratory Disease · 2023

DOI: 10.1177/17534666231169472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2023. Verfasst von Joon Young Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic Uni…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Asthma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Health & Welfare, Republic of Korea, Ministry of Education, Research Program funded Korea National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A considerable proportion of patients have features of both asthma and chronic obstructive pulmonary disease (COPD) simultaneously, called asthma–COPD overlap (ACO).

Objectives

The aim of this study was to identify heterogeneity of ACO from a cohort of patients with severe asthma and COPD using the same diagnostic criteria.

Design

We used the International Severe Asthma Registry (ISAR) and the Korean COPD Subgroup Study (KOCOSS) to evaluate clinical characteristics of ACO from each cohort.

Methods

We classified subjects into four groups: (1) pure severe asthma, (2) ACO from the severe asthma cohort, (3) ACO from the COPD cohort, and (4) pure COPD. ACO was defined by satisfying extreme bronchodilator response (BDR) >15% and 400 ml and/or blood eosinophil count ⩾300 /µL in patients aged 40 years or older and post-BD forced expiratory volume in 1 s (FEV 1 )/forced vital capacity (FVC) ratio

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveAsthmaMaleHumansLungForced Expiratory VolumeVital Capacity

Stichwörter der Autor:innen

ACOCOPDasthmaexacerbationheterogeneity

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Division of Pulmonary and allergy Medicine, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Republic of Korea.
  • Division of Pulmonary Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University Medical School, Anyang, Republic of Korea.
  • Division of Pulmonology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, University of Inje College of Medicine, Busan, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID-Profile: Joon Young Choi, Chin Kook Rhee, Yong Suk Jo

Förderung

  • Ministry of Health & Welfare, Republic of Korea
  • Ministry of Education
  • Research Program funded Korea National Institute of Health

Zitieren

APA

Choi, J. Y., Rhee, C. K., Yoo, K. H., Jung, K. S., Lee, J. H., Yoon, H. K., Ra, S. W., Lee, M. G., & Jo, Y. S. (2023). Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666231169472

Vancouver

Choi JY, Rhee CK, Yoo KH, Jung KS, Lee JH, Yoon HK, et al. Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD. Therapeutic Advances in Respiratory Disease. 2023. doi:10.1177/17534666231169472

BibTeX
@article{Choi2023,
  author = {Choi, Joon Young and Rhee, Chin Kook and Yoo, Kwang Ha and Jung, Ki-Suck and Lee, Jae Ha and Yoon, Hyoung Kyu and Ra, Seung Won and Lee, Myung Goo and Jo, Yong Suk},
  title = {Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2023},
  doi = {10.1177/17534666231169472}
}
Kostenlos starten →